I
Inovio Pharmaceuticals, Inc. (INO)
NCM – Real vaqt narxi. Valyuta: USD
1.10
+0.02 (1.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.09
-0.01 (-0.91%)
Bozordan keyin: Jun 26, 2026, 7:54 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.10
+0.02 (1.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.09
-0.01 (-0.91%)
Bozordan keyin: Jun 26, 2026, 7:54 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.04 | 6.05 | 7.0 | |
| Tezkor likvidlik nisbati | 1.04 | 5.63 | 7.0 | |
| Qarz/Kapital nisbati | 1.43 | 0.30 | 5.0 | |
| Qarz/Aktivlar nisbati | 0.17 | 1.04 | 8.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 5.6 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 10M | 832K | 218K | 65K | N/A |
| Yalpi foyda | 5M | -3M | -3M | -3M | -3M |
| Operatsion daromad | -274M | -135M | -114M | -87M | -84M |
| Sof foyda | -280M | -135M | -107M | -85M | -85M |
| EBITDA | -269M | -132M | -111M | -84M | -81M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | 59.28 | 5.5 |
| Keyingi chorak | N/A | 74.17 | 5.5 |
| Joriy yil | 16551.75 | 50.66 | 10 |
| Keyingi yil | 534.83 | 56.92 | 10 |
| O‘rtacha ball | 7.8 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | -622.79 | -566.66 | -10.73 | 3.3 |
| Yil/Yil | -99.99 | 0.06 | 45.1 | 19.83 | 5.5 |
| 3 yil o‘rtacha | -78.55 | 31.04 | 48.65 | 24.57 | 7.8 |
| 5 yil o‘rtacha | 33.3 | 3.7 | 25.95 | 10.55 | 7.8 |
| O‘rtacha ball | 6.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Kompaniyaning naqd pul zahiralari $26.3M umumiy qarzdan $8.7M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $39.4M jami joriy majburiyatlardan $37.9M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (1.4) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$21.6M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi